💊 Product Benefits

• Effective in Hormone-Responsive Breast Cancer: Lerozol 2.5 mg inhibits estrogen production, slowing the growth of hormone-sensitive breast cancer cells.

• Adjuvant Therapy: Used after surgery or radiation to reduce the risk of cancer recurrence in postmenopausal women.

• Advanced Cancer Management: Effective in treating advanced or metastatic breast cancer in postmenopausal women.

• Well-Tolerated: Generally well-tolerated with a manageable side effect profile.

⚕️ Indications

• Adjuvant Treatment: For postmenopausal women with hormone receptor-positive early breast cancer.

• Extended Adjuvant Therapy: For patients who have received 5 years of adjuvant tamoxifen therapy.

• First-Line Treatment: For postmenopausal women with hormone receptor-positive or unknown receptor status advanced breast cancer.

• Post-Antiestrogen Therapy: For women with advanced breast cancer who have previously been treated with antiestrogens.

• Preoperative Therapy: To allow breast-conserving surgery in postmenopausal women with localized hormone receptor-positive breast cancer.